Search

ATLANTA— In patients with a variety of cancers oral therapy with edoxaban—a direct oral anticoagulant (DOAC)—was just as effective and safe in terms of the risks of recurrent venous thromboembolism (V

ATLANTA—Adding anti-BCL-2 therapy with the small-molecule drug venetoclax (VEN) to standard low-dose cytarabine (LDAC) chemotherapy tripled response rates over historical comparators and extended surv

ATLANTA—Subcutaneous administration of the anti-CD 38 monoclonal antibody daratumumab could help more patients get this emerging therapy more easily for their advanced or recently-diagnosed multiple m

SOURCE: Pediatric Physical Therapy journal ARTICLE “Trends in Attitudes and Practice Patterns of Physical Therapists in Addressing Childhood Obesity in Schools”[url=http://journals.lww.com

Uptake of the Congenital Muscular Torticollis Guidelines Survey findings about the effectiveness of a recently-introduced clinical practice guideline for congenital muscular torticollis therapy are re

NEW YORK— A case series of two children with benign paroxysmal positional vertigo (BPPV) is reported in Pediatric Physical Therapy journal by Jennifer L. Fay, PT, DPT, NCS, Neurologic Clinical Special

MILAN, Italy—Genomic profiling could help reduce the risk of over-treatment in primary prostate cancer (PC) by identifying patients and healthy individuals whose genes put them at greatest risk of dev

MILAN, Italy—The first choice of therapy for patients with metastatic kidney cancer who have failed VEGF therapy has changed according to experts at the 2016 European Multidisciplinary Meeting

MILAN, Italy—Patients with node-positive prostate cancer being treated with prostatectomy could derive benefit from early multimodality therapy combining androgen deprivation therapy (ADT) with radiot

ARTICLE MILAN, Italy—Genomic testing combined with clinical assessment could be the best way to identify patients with prostate cancer who can benefit from early radiotherapy after prostatectomy, acco

April 15, 2017 Active Surveillance for Renal Cell Cancer MILAN, Italy—Criteria for withholding aggressive therapies early in the course of renal cell cancer were updated at the 2016 European Mu

Audio Journal of Oncology AMSTERDAM—Women diagnosed with ductal carcinoma in situ (DCIS) of the breast were found to live longer than women in the general population according to a study from the Neth